Equities analysts expect that Heska Corp (NASDAQ:HSKA) will announce earnings per share of $0.56 for the current quarter, Zacks reports. Two analysts have issued estimates for Heska’s earnings. The highest EPS estimate is $0.59 and the lowest is $0.53. Heska reported earnings of $0.46 per share in the same quarter last year, which would indicate a positive year over year growth rate of 21.7%. The firm is expected to announce its next earnings report before the market opens on Wednesday, February 28th.
On average, analysts expect that Heska will report full year earnings of $2.01 per share for the current year, with EPS estimates ranging from $1.97 to $2.04. For the next year, analysts forecast that the business will report earnings of $2.09 per share, with EPS estimates ranging from $1.91 to $2.25. Zacks Investment Research’s earnings per share averages are an average based on a survey of sell-side research analysts that that provide coverage for Heska.
Several equities research analysts recently commented on the company. Sidoti raised Heska from a “neutral” rating to a “buy” rating and set a $94.00 price objective on the stock in a research report on Monday, February 5th. ValuEngine cut Heska from a “hold” rating to a “sell” rating in a research report on Friday, February 2nd. BidaskClub cut Heska from a “sell” rating to a “strong sell” rating in a research report on Wednesday, January 31st. Zacks Investment Research cut Heska from a “hold” rating to a “sell” rating in a research report on Wednesday, January 3rd. Finally, Aegis reissued a “buy” rating on shares of Heska in a research report on Tuesday, December 19th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $110.08.
A number of large investors have recently made changes to their positions in the business. The Manufacturers Life Insurance Company boosted its position in Heska by 6.1% in the second quarter. The Manufacturers Life Insurance Company now owns 5,112 shares of the medical research company’s stock worth $522,000 after purchasing an additional 294 shares during the last quarter. Voya Investment Management LLC raised its stake in shares of Heska by 15.2% in the second quarter. Voya Investment Management LLC now owns 3,002 shares of the medical research company’s stock worth $306,000 after buying an additional 395 shares during the period. Royal Bank of Canada raised its stake in shares of Heska by 96.9% in the second quarter. Royal Bank of Canada now owns 1,014 shares of the medical research company’s stock worth $103,000 after buying an additional 499 shares during the period. New York State Common Retirement Fund raised its stake in shares of Heska by 5.8% in the second quarter. New York State Common Retirement Fund now owns 9,597 shares of the medical research company’s stock worth $980,000 after buying an additional 525 shares during the period. Finally, Cadence Capital Management LLC raised its stake in shares of Heska by 5.1% in the third quarter. Cadence Capital Management LLC now owns 14,859 shares of the medical research company’s stock worth $1,309,000 after buying an additional 720 shares during the period. 78.71% of the stock is currently owned by institutional investors and hedge funds.
Shares of Heska (NASDAQ:HSKA) opened at $60.59 on Monday. Heska has a 12-month low of $56.59 and a 12-month high of $115.00. The company has a market capitalization of $438.90, a price-to-earnings ratio of 31.72, a P/E/G ratio of 1.57 and a beta of 0.67.
COPYRIGHT VIOLATION WARNING: This report was originally published by Ticker Report and is the property of of Ticker Report. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.tickerreport.com/banking-finance/3223223/heska-corp-hska-expected-to-announce-earnings-of-0-56-per-share.html.
Heska Company Profile
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.